Find Funding Opportunities

-Purpose. This funding opportunity facilitates collaborative basic biomedical research between scientists supported by the National Institutes of Health (NIH) and investigators in developing countries. For behavioral and social sciences research, see the companion Funding Opportunity Announcement (FOA), Fogarty “International Research Collaboration – Behavioral, Social Sciences” Research Award program (FIRCA-BSS) (PAR-06-437).  -Mechanism of Support. This FOA will utilize the NIH R03 Small Grant mechanism, with additional eligibility, project period, and funding restrictions. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The anticipated number of awards is 30 to 40 per year.

-Purpose. The purpose of this initiative is to provide funding opportunities for the increasing pool of foreign basic and biomedical scientists, clinical investigators, nurses and other health professionals with state-of-the-art knowledge of research methods to advance critical issues in global health upon their return to their home low- or middle-income countries through basic and biomedical sciences research and technology development. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. The total amount to be awarded is $300,000 and the anticipated number of awards is six.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award may also vary; however, individual awards are limited to a maximum of $50,000 direct costs per year.The total amount awarded and the number of awards will depend upon the quality and costs of the applications received.

-Purpose. Biomedical research laboratories increasingly undertake a software development project to solve a problem of interest to that laboratory. These software packages sometimes become useful to a much broader community of users that can include translational and clinical researchers. The goal of this program announcement is to support the continued development, maintenance, testing and evaluation of existing software. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing biomedical informatics/computational biology software to a broader biomedical research community. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award. -Funds Available and Anticipated Number of Awards Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon number, quality, duration, and costs of the applications received.

-Purpose. To encourage interdisciplinary, investigator-initiated translational research in the science of critical care. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

-Purpose. The goal of this funding opportunity announcement (FOA) is to invite Research Project Grant (R01) applications investigating the role of diet composition in energy balance, including studies in both animals and humans.Both short and longer-term studies are encouraged, ranging from basic studies investigating the impact of micro-or macronutrient composition on appetite, metabolism, and energy expenditure through clinical studies evaluating the efficacy of diets differing in micro- or macronutrient composition, absorption, dietary variety, or energy density for weight loss or weight maintenance. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.

-Purpose. This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). It solicits R01 grant applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying the phases of migraine and the role of neuromodulators such as sex hormones, and genetic influences in migraine pathophysiology. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-306, Neurobiology ofMigraine (R21), that solicits applications under the NIH Exploratory/Developmental Grant (R21) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

-Purpose. This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). It solicits R21 grant applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying the phases of migraine and the role of neuromodulators, such as sex hormones, and genetic influences in migraine pathophysiology. -Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-305, Neurobiology ofMigraine (R01), that solicits applications under the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.

-Purpose. Metabolomics enables simultaneous identification and analysis of multiple metabolites in cells, tissues and body fluids. This Funding Opportunity Announcement (FOA) is an initiative sponsored by several NIH institutes to promote the application of metabolomic technologies for translational research in human health and disease to enable/improve disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-302 that solicits applications under the R21 mechanism for pilot/exploratory projects. -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

-Purpose. Metabolomics enables simultaneous identification and analysis of multiple metabolites in cells, tissues and body fluids. This Funding Opportunity Announcement (FOA) is an initiative sponsored by several NIH institutes to promote the application of metabolomic technologies for translational research in human health and disease to enable/improve disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses. -Mechanism of Support. This FOA will utilize the NIH exploratory R21 award mechanism for pilot research projects and runs in parallel with an FOA of identical scientific scope, PA -07-301, that solicits applications under the R01 grant mechanism. -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

-Purpose. This Funding Opportunity Announcement (FOA) is a request for applications (RFA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). It solicits R01 grant applications from institutions/organizations that propose research to assess the susceptibility, risk factors, mechanisms, and preventive measures relevant to the progressive nature of migraine headaches. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. The NINDS has set aside $1.1 million dollars to be awarded in FY 2007. It is anticipated that 3-4 applications will be funded. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.